Dabigatran vs Trastuzumab

## Dabigatran vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Dabigatran** and **Trastuzumab**.

## Mechanism of Action

**Dabigatran**: Direct thrombin (Factor IIa) inhibitor.

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Dabigatran — 12-17 hours; Trastuzumab — 28 days.

## Chemical Properties

**Molecular Formula**: Dabigatran — C25H25N7O3; Trastuzumab — N/A.

**Molecular Weight**: Dabigatran — 471.5100 g/mol; Trastuzumab — N/A.

**Type**: Dabigatran — Small molecule; Trastuzumab — Antibody.